Dr. Kehinde O Ogunmakin , MD
Dermatology โข Houston, TX
1111 Augusta Dr
Houston, TX 77057
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on August 17, 2011; this date does not establish years in practice.
-
Published CMS data list 168 Original Medicare Part B services in 2018.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2018. Published rows only; this is not a quality measure.
-
Published Part B service records, 2018:
- 17003 โ Destruction of precancer skin growth, 2-14 growths: 52 service units.
- 99214 โ Established patient outpatient office visit: 28 service units.
- 99213 โ Established patient outpatient office visit: 25 service units.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2018. Units differ by code; these are not visits or a measure of quality.
CPTยฎ only copyright 2017 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2018). CPT notice
See all 7 records in the table ยท Guide: How to read Medicare Part B data
-
Published CMS data list 874 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Ketoconazole โ 229 prescription fills, including refills.
- Triamcinolone Acetonide โ 86 prescription fills, including refills.
- Minoxidil โ 85 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 18 records in the table ยท Guide: How to read Medicare Part D prescriber data
-
More Part D prescriptions than 80% of clinicians listed under Dermatology in Houston, TX (2024, 131 clinicians with data). Median for this group: 359. Middle half: 150 to 659.
More Part D prescriptions than 70% of clinicians listed under Dermatology in Texas (2024, 922 clinicians with data). Median for this group: 486. Middle half: 202 to 949.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 535 in 2017 to 168 in 2018.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2017โ2018.
Practice Location & Contact Primary Location
1111 Augusta Dr
Houston, TX 77057
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
NPPES lists 1 additional practice-address record in Houston, TX. See the list
Source: CMS NPPES NPI Registry, practice location records; release date unavailable.
CMS Doctors and Clinicians lists 1 group name: Kelsey-Seybold Medical Group, Pllc. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
University Of Texas Medical Branch At Galveston
2011
What Public CMS Data Show
Dermatology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare-allowed amount
About $10,371 in 2018
The total amount Medicare approved for these services in 2018. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2018.
Paid by Medicare
About $7,396 in 2018
The part of the Medicare-allowed amount that Medicare itself paid in 2018, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2018.
30-day fills
1,124 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$37,807 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $657.95 across 6 records.
By nature of payment
- Food and Beverage: $657.95 across 6 records.
Reporting-company totals (3 largest of 5)
- Galderma Laboratories, L.P.: $164.06 across 2 records.
- Sanofi and Genzyme US Companies: $135.65 across 1 record.
- Bristol Myers Squibb Company: $122.10 across 1 record.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
15 years (graduated 2011)
CMS Doctors and Clinicians data list 2011 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2011
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, โDoes your provider accept Medicare as full payment?โ
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Ogunmakin has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Ogunmakin as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Houston and Texas
Billing and prescribing volume is not a quality rating.
Medicare Part D prescriptions
More Part D prescriptions than 80% of clinicians listed under Dermatology in Houston, TX (2024, 131 clinicians with data). Median for this group: 359. Middle half: 150 to 659.
More Part D prescriptions than 70% of clinicians listed under Dermatology in Texas (2024, 922 clinicians with data). Median for this group: 486. Middle half: 202 to 949.
Part D drug cost
Close to the middle for clinicians listed under Dermatology in Houston, TX (2024, 131 clinicians with data). Median for this group: $28,743. Middle half: $3,848 to $161,333.
Close to the middle for clinicians listed under Dermatology in Texas (2024, 922 clinicians with data). Median for this group: $81,547. Middle half: $6,986 to $226,319.
Medicare Part B
Comparisons use 2024 data. The latest CMS data for Dr. Ogunmakin are from 2018.
168 active clinicians are listed under Dermatology with a practice address in Houston, TX (1,173 in Texas).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Houston
5.4% of these 168 clinicians have the CMS telehealth indicator.
66.7% of these 168 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services decreased 69% from 535 in 2017 to 168 in 2018.
- 2017: 535
- 2018: 168
-
Medicare-allowed amount
Medicare-allowed amount decreased 65% from $30,023 in 2017 to $10,371 in 2018.
- 2017: $30,023
- 2018: $10,371
-
Paid by Medicare
Paid by Medicare decreased 64% from $20,615 in 2017 to $7,396 in 2018.
- 2017: $20,615
- 2018: $7,396
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 247% from 252 in 2020 to 874 in 2024.
- 2020: 252
- 2021: 400
- 2022: 556
- 2023: 906
- 2024: 874
-
30-day fills
30-day fills increased 341% from 255 in 2020 to 1,124 in 2024.
- 2020: 255
- 2021: 421
- 2022: 613
- 2023: 1,076
- 2024: 1,124
-
Part D drug cost
Part D drug cost increased 193% from $12,914 in 2020 to $37,807 in 2024.
- 2020: $12,914
- 2021: $28,232
- 2022: $69,702
- 2023: $44,012
- 2024: $37,807
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $17.48 in 2021 to $657.95 in 2025.
- 2021: $17.48
- 2022: $69.84
- 2023: $121.86
- 2024: $322.23
- 2025: $657.95
Sources: CMS Medicare Physician & Other Practitioners (2018), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo ยท Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 โ December 31, 2025): fewer than 11 records totaling $657.95.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Galderma Laboratories, L.P. |
Food and Beverage
In-kind items and services
|
NEMLUVIO | General | $141.27 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $135.65 |
| Bristol Myers Squibb Company |
Food and Beverage
Cash or cash equivalent
|
Sotyktu | General | $122.10 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $120.85 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
LITFULO | General | $115.29 |
| Galderma Laboratories, L.P. |
Food and Beverage
In-kind items and services
|
AKLIEF | General | $22.79 |
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPTยฎ is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016โ2017 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners โ by Provider and Service data, 2017โ2018; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
17003
Destruction of precancer skin growth, 2-14 growths
|
52 | 15 | $6.75 | $5.22 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
28 | 27 | $132.50 | $102.72 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
25 | 18 | $79.69 | $70.67 |
|
17000
Destruction of precancer skin growth, 1 growth
|
20 | 19 | $72.53 | $57.49 |
|
11100
Biopsy of single growth of skin and/or tissue
|
16 | 16 | $139.19 | $93.62 |
|
17110
Destruction of skin growth, 1-14 growths
|
15 | 15 | $127.84 | $106.14 |
|
99203
New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
|
12 | 12 | $141.51 | $101.44 |
Source: CMS Part B by Provider and Service, 2018; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Ketoconazole | Ketoconazole | 229 | 7,617 | $2,411.49 | 122 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 86 | 2,359 | $631.32 | 71 |
| Minoxidil | Minoxidil | 85 | 7,203 | $2,064.00 | 29 |
| Tacrolimus | Tacrolimus | 65 | 1,940 | $12,895.54 | 43 |
| Ammonium Lactate | Ammonium Lactate | 58 | 2,066 | $1,122.44 | 29 |
| Clobetasol Propionate | Clobetasol Propionate | 56 | 1,675 | $5,665.54 | 41 |
| Fluorouracil | Fluorouracil | 50 | 1,524 | $2,473.77 | 45 |
| Hydrocortisone | Hydrocortisone | 49 | 849 | $204.68 | 41 |
| Fluocinolone Acetonide | Fluocinolone/Shower Cap | 35 | 1,110 | $984.44 | 17 |
| Clindamycin Phosphate | Clindamycin Phosphate | 27 | 898 | $683.10 | 20 |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 25 | 784 | $1,051.27 | 21 |
| Mupirocin | Mupirocin | 24 | 372 | $138.55 | 23 |
| Fluocinonide | Fluocinonide | 22 | 705 | $1,816.87 | 17 |
| Metronidazole | Metronidazole | 17 | 575 | $473.53 | โ |
| Azelaic Acid | Azelaic Acid | 13 | 390 | $749.24 | โ |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 11 | 885 | $2,468.06 | โ |
| Tretinoin | Tretinoin | 11 | 299 | $507.67 | โ |
| Dutasteride | Dutasteride | 11 | 750 | $1,465.86 | โ |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2021-06-14NUCC Taxonomy Code: 207N00000X
A dermatologist is trained to diagnose and treat pediatric and adult patients with benign and malignant disorders of the skin, mouth, external genitalia, hair and nails, as well as a number of sexually transmitted diseases. The dermatologist has had additional training and experience in the diagnosis and treatment of skin cancers, melanomas, moles and other tumors of the skin, the management of contact dermatitis and other allergic and nonallergic skin disorders, and in the recognition of the skin manifestations of systemic (including internal malignancy) and infectious diseases. Dermatologists have special training in dermatopathology and in the surgical techniques used in dermatology. They also have expertise in the management of cosmetic disorders of the skin such as hair loss and scars and the skin changes associated with aging.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - DERMATOLOGY
I20151019002090
TX
3870802622
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Kelsey-Seybold Medical Group, Pllc
1111 Augusta Dr, Houston, TX 770572209
Phone: 7134422400
Secondary Practice Locations
929 Gessner Rd Ste 1450
Houston, TX 770242317
Phone: 7134425200
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Family Medicine
Doctor of Medicine (M.D.)
Internal Medicine
Doctor of Medicine (M.D.)
Internal Medicine
Doctor of Medicine (M.D.)
Urology
Doctor of Medicine (M.D.)
Internal Medicine
Doctor of Medicine (M.D.)
Physical Medicine & Rehabilitation
Doctor of Medicine (M.D.)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 1111 AUGUSTA DR, HOUSTON, TX 77057 (Tel: 7134422400)
Registered at 11511 SHADOW CREEK PKWY, PEARLAND, TX 775847298 (Tel: 7134420000)
Dermatology (license number reported to NPPES: TX Q2596)
NPI status registered as active in NPPES database
Registered at 3601 4TH ST, DEPARTMENT OF DERMATOLOGY, LUBBOCK, TX 794309400 (Tel: 8067432463)
Registered at 3601 4TH ST, DEPARTMENT OF DERMATOLOGY, LUBBOCK, TX 794309400 (Tel: 8067432463)
Recorded as KEHINDE OGUNMAKIN, M.D
Dermatology (license number reported to NPPES: TX BP20043357)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Dermatology Specialists in Houston
- Dr. Josie Pielop, MD
- Dr. Adrienne Choksi, MD
- Dr. Madeleine Gantz, MD
- Dr. Katherine Cox, MD
- Dr. Emily Mintz, MD
- Dr. Marie Maurice, MD
Mailing Address
11511 Shadow Creek Pkwy
Pearland, TX 775847298
Phone: 7134420000